Kunshan Kinglai Hygienic Materials Co.,Ltd.

SZSE:300260 Rapport sur les actions

Capitalisation boursière : CN¥7.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Kunshan Kinglai Hygienic MaterialsLtd Croissance future

Future contrôle des critères 6/6

Kunshan Kinglai Hygienic MaterialsLtd is forecast to grow earnings and revenue by 34.1% and 21.4% per annum respectively. EPS is expected to grow by 33.9% per annum. Return on equity is forecast to be 20.2% in 3 years.

Informations clés

34.1%

Taux de croissance des bénéfices

33.9%

Taux de croissance du BPA

Machinery croissance des bénéfices26.2%
Taux de croissance des recettes21.4%
Rendement futur des capitaux propres20.2%
Couverture par les analystes

Low

Dernière mise à jour03 Jun 2024

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Earnings Tell The Story For Kunshan Kinglai Hygienic Materials Co.,Ltd. (SZSE:300260)

Jun 30
Earnings Tell The Story For Kunshan Kinglai Hygienic Materials Co.,Ltd. (SZSE:300260)

Investors Will Want Kunshan Kinglai Hygienic MaterialsLtd's (SZSE:300260) Growth In ROCE To Persist

Jun 11
Investors Will Want Kunshan Kinglai Hygienic MaterialsLtd's (SZSE:300260) Growth In ROCE To Persist

We Think Kunshan Kinglai Hygienic MaterialsLtd (SZSE:300260) Is Taking Some Risk With Its Debt

May 24
We Think Kunshan Kinglai Hygienic MaterialsLtd (SZSE:300260) Is Taking Some Risk With Its Debt

Why Investors Shouldn't Be Surprised By Kunshan Kinglai Hygienic Materials Co.,Ltd.'s (SZSE:300260) 38% Share Price Surge

Mar 02
Why Investors Shouldn't Be Surprised By Kunshan Kinglai Hygienic Materials Co.,Ltd.'s (SZSE:300260) 38% Share Price Surge

Kunshan Kinglai Hygienic MaterialsLtd (SZSE:300260) Is Doing The Right Things To Multiply Its Share Price

Feb 28
Kunshan Kinglai Hygienic MaterialsLtd (SZSE:300260) Is Doing The Right Things To Multiply Its Share Price

Prévisions de croissance des bénéfices et des revenus

SZSE:300260 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20264,990674N/A4862
12/31/20254,164521N/A3012
12/31/20243,319364N/A3172
3/31/20242,761251-192205N/A
12/31/20232,711236-220219N/A
9/30/20232,606238-300-24N/A
6/30/20232,664299-59201N/A
3/31/20232,630319-317-58N/A
1/1/20232,620345-252-26N/A
9/30/20222,56732413251N/A
6/30/20222,382258-18720N/A
3/31/20222,25621850240N/A
1/1/20222,05417023174N/A
9/30/20211,821140-30112N/A
6/30/20211,6131179131N/A
3/31/20211,4781043119N/A
12/31/20201,3238315109N/A
9/30/20201,37277-4316N/A
6/30/20201,350653393N/A
3/31/20201,320611967N/A
12/31/20191,387624290N/A
9/30/20191,3495392146N/A
6/30/20191,339471965N/A
3/31/20191,34744134168N/A
12/31/20181,17539131157N/A
9/30/201899340145165N/A
6/30/201880131139154N/A
3/31/2018657243952N/A
12/31/201763822N/A39N/A
9/30/201761621N/A-17N/A
6/30/201759622N/A30N/A
3/31/201753814N/A60N/A
12/31/201649012N/A72N/A
9/30/20164372N/A35N/A
6/30/2016424-1N/A-35N/A
3/31/20164291N/A-62N/A
12/31/20154272N/A-57N/A
9/30/20154427N/A-12N/A
6/30/20154287N/A-10N/A
3/31/20154288N/A-7N/A
12/31/20144229N/A-19N/A
9/30/20143998N/A-19N/A
6/30/20144159N/A-25N/A
3/31/201443512N/A-30N/A
12/31/201344313N/A-37N/A
9/30/20134305N/A7N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 300260's forecast earnings growth (34.1% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 300260's earnings (34.1% per year) are forecast to grow faster than the CN market (21.9% per year).

Croissance élevée des bénéfices: 300260's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 300260's revenue (21.4% per year) is forecast to grow faster than the CN market (13.4% per year).

Croissance élevée des revenus: 300260's revenue (21.4% per year) is forecast to grow faster than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 300260's Return on Equity is forecast to be high in 3 years time (20.2%)

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y